Charles Moore
Stock Analyst at Robert W. Baird
(0.68)
# 4,153
Out of 5,040 analysts
9
Total ratings
11.1%
Success rate
-11.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Moore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics | Reiterated: Buy | $20 → $19 | $13.18 | +44.16% | 3 | Sep 15, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $34 | $18.67 | +82.11% | 3 | Aug 7, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $142 → $126 | $52.00 | +142.31% | 3 | Feb 13, 2026 |
Contineum Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $20 → $19
Current: $13.18
Upside: +44.16%
Denali Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $34
Current: $18.67
Upside: +82.11%
Bright Minds Biosciences
Feb 13, 2026
Reiterated: Buy
Price Target: $142 → $126
Current: $52.00
Upside: +142.31%